iodophenyl metomidate

Known as: iodometomidate 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2017
01220082017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Primary hyperaldosteronism, characterised by hypertension and hypokalaemia, is a syndrome caused by aldosterone excess most… (More)
  • figure 1
Is this relevant?
Review
2017
Review
2017
Understanding the pharmacologic options for pediatric sedation outside the operating room will allow practitioners to formulate… (More)
Is this relevant?
2014
2014
BACKGROUND Cyclopropyl-methoxycarbonyl metomidate (CPMM) is a "soft" etomidate analogue currently being developed as a propofol… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2013
2013
The application of radiolabelled inhibitors of cytochrome P450 enzymes is a novel approach for molecular imaging of… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2008
2008
BACKGROUND Due to advances in conventional imaging, adrenal tumors are detected with increasing frequency. However, conventional… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2008
2008
Derivatives of etomidate were evaluated as inhibitors of adrenal steroid 11beta-hydroxylations. Stereoselective coupling by… (More)
  • figure 1
  • figure 2
  • table 3
  • figure 3
  • table 4
Is this relevant?